378203-86-2

Basic information

• Product Name: 1H-Pyrazole-3-carboxylicacid,1-methyl-4-nitro-,ethylester(9CI)
• Synonyms: 1H-Pyrazole-3-carboxylicacid,1-methyl-4-nitro-,ethylester(9CI)
• CAS NO: 378203-86-2
• Molecular Formula: C7H9N3O4
• Molecular Weight: 199.16
• Product Categories: CARBOXYLICESTER
• Mol File: 378203-86-2.mol

Chemical Properties

• Boiling Point: 318.0±22.0 °C(Predicted)
• Appearance: /
• Density: 1.42±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: -4.36±0.10(Predicted)
• CAS DataBase Reference: 1H-Pyrazole-3-carboxylicacid,1-methyl-4-nitro-,ethylester(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrazole-3-carboxylicacid,1-methyl-4-nitro-,ethylester(9CI)(378203-86-2)
• EPA Substance Registry System: 1H-Pyrazole-3-carboxylicacid,1-methyl-4-nitro-,ethylester(9CI)(378203-86-2)

Safety Data

• Hazardous Substances Data: 378203-86-2(Hazardous Substances Data)

Usage

Structure

A pyrazole ring with a carboxylic acid group, a nitro group, and a methyl group attached to the ethyl ester.

Type

A chemical compound and a derivative of pyrazole.

Usage

Commonly used as a building block in organic synthesis for the production of pharmaceuticals, agrochemicals, and other fine chemicals. Also has potential applications as an intermediate in the production of dyes and pigments.

Hazards

Potential hazards to the environment and health. It should be handled with care.

Upstream product

• 88529-79-7 ethyl 1-methyl-1H-pyrazole-3-carboxylate 
• 55864-87-4 4-nitro-1H-pyrazole-3-carboxylic acid ethyl ester 
• 74-88-4 methyl iodide 

Downstream Products

• 1617523-37-1 C₁₅H₁₇N₃O₆ 

Relevant articles and documents

FGFR4 INHIBITORS

We provide FGFR inhibitors, their salts, methods of manufacture, and methods of use.

FUSED BICYCLIC HETEROAROMATIC DERIVATIVES AS KINASE INHIBITORS

A series of fused bicyclic heteroaromatic derivatives of formula (IA) or (IB), as defined herein, being selective inhibitors of phosphatidylinositol-4-kinase IIIβ (PI4KIIIβ) activity, are beneficial in the treatment and/or prevention of various human ailm

Pyrazolyl-Based Carboxamides II

The invention relates to pyrazolyl-based carboxamide compounds useful as ICRAC inhibitors, to pharmaceutical compositions containing these compounds and to these compounds for the use in the treatment and/or prophylaxis of diseases and/or disorders, in particular inflammatory diseases and/or inflammatory disorders.

PYRAZOLYL-BASED CARBOXAMIDES II AS CRAC CHANNEL INHIBITORS

The invention relates to pyrazolyl-based carboxamide compounds of formula (I) useful as ICRAC inhibitors, to pharmaceutical compositions containing these compounds and to these compounds for the use in the treatment and/or prophylaxis of diseases and/or disorders, in particular inflammatory diseases and/or inflammatory disorders.